September 12, 2019

Dr. Stromnes was awarded the 2019 Julia Stagliano Pancreatic Cancer Action Network Catalyst Grant for her research project "Overcoming Immunotherapy Resistance in Pancreas Cancer".

 "I am incredibly honored to receive support from the Pancreatic Cancer Action Network for funding our research to develop safe and effective immunotherapies for pancreas cancer," said Stromnes. "My team is also enormously grateful for the generosity of Nancy Stagliano, who in memory of Julia Stagliano, supports pancreas cancer immunotherapy research."  The Pancreatic Cancer Action Network (PanCAN) in partnership with generous donors, awarded grants to support pancreatic cancer research, for the full list see 2019 research grants. Through a highly competitive peer-review process, seven researchers across the U.S. were selected, bringing PanCAN’s total projected research investment to approximately $104 million, including its grants program and clinical and scientific initiatives. PanCAN’s competitive grants program funds promising and high-caliber research on pancreatic cancer. This is the 17th year of the research grant program, and the organization has awarded 174 grants to 170 scientists at 64 institutions. This is Dr. Stromnes’ second grant from the Pancreatic Cancer Action Network (PanCAN). She was previously awarded the Skip Viragh Career Development Award in 2017. To learn more about Dr. Stromnes project, click here. Congratulations to Dr. Ingunn Stromnes.

PanCan Action Network provides us with an in depth interview with each investigator to share what drives them to work in the pancreatic cancer field, view Dr. Stromnes interview here.